Anne Nagengast Johnson, Chief Financial Officer at ATAI Life Sciences N.V. (ATAI), sold 54,820 shares at $1.85 ($101K) on 2024-04-02, disclosed to the SEC on 2024-04-04.
Open-market sale of $101k ATAI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.85 | 27,410 | $51K | 50.0% |
| 2 | $1.85 | 27,410 | $51K | 50.0% |
| Total | $1.85 avg | 54,820 | $101K | 100% |